Oxaliplatin Recruiting Phase 1 Trials for Peritoneal Carcinomatosis Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03172416Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin And In Combination With Nivolumab In Patients With Peritoneal Carcinomatosis